Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___	O
Chief	O
Complaint:	O
Shortness	O
of	O
breath	O
with	O
subsequent	O
anterior	O
STEMI	O
complicated	O
by	O
cardiogenic	O
shock	O
following	O
primary	O
PCI	O
prompting	O
transfer	O
to	O
the	O
___	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
at	O
___	O
History	O
of	O
Present	O
Illness:	O
___	O
year-old	O
man	O
with	O
H/O	O
GERD,	O
untreated	O
hypertension,	O
probable	O
hyperlipidemia,	O
and	O
osteoarthritis	O
with	O
a	O
very	O
unhealthy	O
lifestyle	O
and	O
multiple	O
CAD	O
risk	O
factors	O
who	O
has	O
been	O
fatigued	O
and	O
listless	O
for	O
a	O
couple	O
of	O
days.	O
On	O
the	O
day	O
of	O
presentation,	O
he	O
developed	O
acute	O
shortness	O
of	O
breath,	O
and	O
EMS	O
was	O
summoned.	O
ECG	O
showed	O
anterior	O
ST	O
elevation	O
with	O
Q	O
waves.	O
In	O
the	O
___	O
___,	O
patient	O
was	O
intubated.	O
He	O
was	O
then	O
taken	O
directly	O
for	O
emergent	O
coronary	O
angiography,	O
showing	O
100%	O
occlusion	O
at	O
ostium	O
of	O
LAD	O
with	O
TIMI	O
0	O
flow	O
treated	O
successfully	O
with	O
one	O
DES	O
with	O
post-procedure	O
TIMI	O
3	O
flow.	O
Lesion	O
was	O
described	O
as	O
high	O
risk,	O
heavily	O
calcified	O
and	O
eccentric.	O
Of	O
note	O
LCx	O
had	O
a	O
focal	O
proximal	O
OM1	O
70-80%	O
stenosis	O
as	O
well	O
as	O
chronic	O
total	O
occlusion	O
of	O
RCA	O
which	O
unable	O
to	O
be	O
engaged,	O
but	O
there	O
were	O
faint	O
left-to-right	O
collaterals.	O
As	O
flow	O
down	O
the	O
LAD	O
was	O
restored,	O
his	O
BP	O
improved	O
to	O
90-100	O
systolic	O
and	O
dopamine	O
was	O
weaned	O
down.	O
IABP	O
was	O
placed	O
at	O
end	O
of	O
procedure	O
with	O
excellent	O
augmentation	O
and	O
MAPs	O
in	O
___.	O
Due	O
to	O
need	O
for	O
management	O
of	O
balloon	O
pump,	O
he	O
was	O
transferred	O
via	O
MedFlight	O
to	O
___.	O
En	O
route,	O
patient	O
on	O
norepinephrine	O
and	O
dopamine	O
with	O
IABP	O
augmented	O
MAP	O
in	O
___.	O
Labs/studies	O
notable	O
for	O
WBC:	O
23.9;	O
Hgb:	O
17.8;	O
Chem	O
7	O
unremarkable	O
with	O
Na	O
137,	O
K	O
4,	O
BUN/Cr	O
___.	O
LDH:	O
251.	O
Troponin	O
I:	O
0.05;	O
no	O
CKMB	O
drawn.	O
On	O
arrival	O
to	O
the	O
CCU,	O
the	O
patient	O
was	O
intubated	O
and	O
on	O
dopamine	O
and	O
norepinephrine.	O
He	O
was	O
slightly	O
cool	O
to	O
touch	O
with	O
MAP	O
in	O
___.	O
Per	O
family,	O
he	O
has	O
had	O
general	O
fatigue	O
for	O
around	O
___	O
years	O
punctuated	O
by	O
worsening	O
exertional	O
dyspnea	O
and	O
vague	O
complaints	O
to	O
his	O
wife	O
about	O
chest	O
pain.	O
Son,	O
___,	O
states	O
that	O
2	O
days	O
ago	O
at	O
his	O
car	O
shop,	O
the	O
patient	O
seemed	O
much	O
slower	O
than	O
usual,	O
seated	O
and	O
breathless	O
and	O
was	O
"looking	O
off".	O
___	O
Procedural	O
Report:	O
CORONARY	O
ANGIOGRAPHY	O
(___)	O
Cardiac	O
Arteries	O
and	O
Lesion	O
Findings	O
LMCA:	O
Angiographically	O
unremarkable.	O
LAD:	O
Multiple	O
stenosis	O
and	O
Acute	O
occlusion.100%	O
at	O
ostium;	O
Faint	O
collaterals	O
to	O
mid	O
vessel	O
and	O
apex.	O
Lesion	O
on	O
___	O
LAD:	O
Ostial.100%	O
stenosis	O
20	O
mm	O
length	O
reduced	O
to	O
0%.	O
Pre	O
procedure	O
TIMI	O
0	O
flow	O
was	O
noted.	O
Post	O
Procedure	O
TIMI	O
III	O
flow	O
was	O
present.	O
The	O
guidewire	O
cross	O
was	O
successful.	O
The	O
lesion	O
was	O
diagnosed	O
as	O
High	O
Risk	O
(C).	O
The	O
lesion	O
was	O
diffuse,	O
eccentric	O
and	O
heavily	O
calcified.The	O
lesion	O
showed	O
evidence	O
of	O
thrombus	O
presence,	O
mild	O
angulation,	O
mild	O
tortuosity	O
and	O
favorable	O
total	O
occlusion.	O
Culprit	O
lesion.	O
LCx:	O
Focal	O
stenosis.OM	O
1	O
has	O
proximal	O
70-80%	O
stenosis	O
RCA:	O
Chronic	O
occlusion.Unable	O
to	O
engage	O
and	O
presume	O
occluded.	O
There	O
are	O
faint	O
L	O
>	O
R	O
collaterals.	O
CONCLUSIONS	O
Procedure	O
Summary	O
Intervention:	O
Note	O
initial	O
BP	O
___	O
systolic.	O
Improved	O
with	O
dopamine	O
to	O
80-90	O
systolic.	O
6	O
___	O
XB	O
LAD	O
3.5	O
provided	O
good	O
support.	O
CPT	O
XS	O
wire	O
to	O
distal	O
LAD.	O
Multiple	O
inflations	O
with	O
2.5	O
and	O
3.0	O
balloons	O
at	O
___	O
ATM	O
with	O
improved	O
flow	O
and	O
probable	O
thrombus.	O
Export	O
catheter	O
with	O
no	O
thrombus	O
and	O
loss	O
of	O
flow.	O
Further	O
ballon	O
inflations	O
with	O
2.5	O
balloon	O
restored	O
flow.2.5	O
x	O
28	O
Promus	O
___	O
at	O
14	O
ATM	O
and	O
proximal	O
segment	O
post-dilated	O
with	O
3.0	O
x	O
15c	O
NC	O
balloon	O
at	O
16	O
ATM.	O
Flow	O
was	O
restored	O
into	O
D1	O
and	O
D2	O
but	O
severe	O
proximal	O
disease	O
noted	O
in	O
D1	O
origin	O
-	O
not	O
jailed.	O
There	O
was	O
competitive	O
flow	O
in	O
distal	O
LAD	O
but	O
no	O
flow	O
into	O
mid	O
vessel.	O
2.0	O
balloon	O
at	O
___	O
ATM	O
throughout	O
improved	O
flow	O
and	O
continuous	O
with	O
competitive	O
flow.	O
Wire	O
then	O
placed	O
into	O
D1	O
and	O
2.0	O
balloon	O
at	O
6	O
ATM.	O
Flow	O
improved	O
but	O
diffusely	O
diseased	O
branch.	O
As	O
flow	O
restored	O
BP	O
improved	O
to	O
90-100	O
systolic	O
and	O
dopamine	O
weaned.	O
IABP	O
placed	O
at	O
end	O
of	O
procedure	O
with	O
excellent	O
augmentation	O
and	O
MAPs	O
in	O
___.	O
Final	O
Diagnosis:	O
1.	O
Severe	O
3	O
vessel	O
CAD.	O
2.	O
Anterior	O
STEMI	O
with	O
occluded	O
LAD.	O
3.	O
Successful	O
___.	O
Recommendations	O
1.	O
Transfer	O
to	O
___.	O
2.	O
IABP.	O
3.	O
ASA	O
81	O
mg	O
daily.	O
4.	O
Ticagrelor	O
90	O
mg	O
BID.	O
Past	O
Medical	O
History:	O
1.	O
CAD	O
RISK	O
FACTORS	O
-	O
Hypertension	O
(untreated)	O
-	O
Dyslipidemia	O
(untreated)	O
2.	O
CARDIAC	O
HISTORY	O
-	O
None	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY	O
-	O
GERD	O
-	O
OA	O
(lumbar-moderate	O
to	O
severe)	O
on	O
oxycodone	O
-	O
H/O	O
syncope	O
___	O
years	O
ago	O
with	O
negative	O
workup	O
per	O
family	O
Social	O
History:	O
___	O
Family	O
History:	O
Adopted,	O
no	O
known	O
family	O
history	O
of	O
heart	O
disease	O
Physical	O
Exam:	O
On	O
admission	O
GENERAL:	O
elderly	O
white	O
man,	O
intubated,	O
slight	O
duskiness	O
to	O
skin	O
color	O
VS:	O
T	O
97.5	O
HR	O
69	O
BP	O
93/48	O
(augmented	O
on	O
IABP)	O
Intubated	O
RR:	O
20	O
on	O
FiO2	O
of	O
80%	O
HEENT:	O
Normocephalic	O
atraumatic.	O
Sclera	O
anicteric.	O
Conjunctiva	O
were	O
pink	O
NECK:	O
Supple.	O
JVP	O
of	O
8	O
cm.	O
CARDIAC:	O
Regular	O
rate	O
and	O
rhythm.	O
Normal	O
S1,	O
S2.	O
No	O
murmurs,	O
rubs,	O
or	O
gallops.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities.	O
Respiration	O
is	O
mechanically	O
ventilated,	O
not	O
overbreathing	O
ventilator.	O
Mild	O
rhonchi	O
diffusely.	O
No	O
crackles,	O
wheezes.	O
ABDOMEN:	O
Soft,	O
non-tender,	O
non-distended.	O
No	O
hepatomegaly.	O
No	O
splenomegaly.	O
EXTREMITIES:	O
Slightly	O
cool	O
to	O
touch	O
legs	O
>	O
arms.	O
No	O
clubbing,	O
cyanosis,	O
or	O
peripheral	O
edema.	O
SKIN:	O
No	O
significant	O
skin	O
lesions	O
or	O
rashes.	O
PULSES:	O
Distal	O
pulses	O
palpable	O
and	O
symmetric.	O
At	O
discharge	O
GENERAL:	O
WDWN	O
in	O
NAD.	O
Talking	O
on	O
phone	O
to	O
family,	O
complaining	O
of	O
being	O
"poked	O
and	O
prodded".	O
Laying	O
comfortably	O
in	O
bed.	O
VS:	O
T	O
98.7	O
BP	O
122-134/71-84	O
HR	O
77	O
RR	O
20	O
O2	O
sat	O
98%	O
on	O
RA	O
Weight:	O
___	O
kg	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
Mucous	O
membranes	O
moist.	O
NECK:	O
JVD	O
not	O
appreciated	O
CARDIAC:	O
RRR,	O
normal	O
S1,	O
S2.	O
No	O
murmurs,	O
rubs	O
or	O
gallops.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
CTAB.	O
ABDOMEN:	O
Soft,	O
non-tender,	O
not	O
distended.	O
Normoactive	O
BS.	O
Obese	O
abdomen	O
BACK:	O
erythematous	O
skin	O
noted	O
on	O
buttocks	O
that	O
has	O
some	O
superficial	O
non-purulent	O
cysts	O
EXTREMITIES:	O
Warm	O
and	O
well	O
perfused.	O
___	O
pulses	O
Dopplerable,	O
1+DP	O
pulses	O
equal	O
bilaterally,	O
trace	O
lower	O
shin	O
edema	O
bilaterally.	O
Right	O
calf	O
pain	O
dorsum	O
on	O
palpation,	O
increased	O
firmness	O
of	O
R	O
calf	O
compared	O
to	O
left	O
calf,	O
overall	O
improving	O
calf	O
exam	O
Arteriotomy	O
site:	O
Right	O
groin	O
+scab	O
+pulse	O
Pertinent	O
Results:	O
___	O
11:36PM	O
BLOOD	O
WBC-19.6*	O
RBC-5.21	O
Hgb-16.0	O
Hct-48.8	O
MCV-94	O
MCH-30.7	O
MCHC-32.8	O
RDW-13.5	O
RDWSD-46.4*	O
Plt	O
___	O
___	O
11:36PM	O
BLOOD	O
___	O
PTT-49.4*	O
___	O
___	O
11:36PM	O
BLOOD	O
Glucose-178*	O
UreaN-12	O
Creat-0.9	O
Na-139	O
K-3.3	O
Cl-97	O
HCO3-28	O
AnGap-17	O
___	O
11:36PM	O
BLOOD	O
Calcium-8.4	O
Phos-3.2	O
Mg-1.7	O
___	O
11:53PM	O
BLOOD	O
Type-ART	O
pO2-84*	O
pCO2-57*	O
pH-7.32*	O
calTCO2-31*	O
Base	O
XS-0	O
___	O
11:53PM	O
BLOOD	O
Lactate-1.8	O
___	O
11:53PM	O
BLOOD	O
Hgb-16.6	O
calcHCT-50	O
O2	O
Sat-95	O
___	O
11:53PM	O
BLOOD	O
freeCa-1.02*	O
___	O
11:36PM	O
BLOOD	O
CK-MB-23*	O
MB	O
Indx-7.9*	O
cTropnT-0.13*	O
___	O
01:18AM	O
URINE	O
Color-Yellow	O
Appear-Clear	O
Sp	O
___	O
___	O
01:18AM	O
URINE	O
Blood-NEG	O
Nitrite-NEG	O
Protein-30	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.0	O
Leuks-NEG	O
___	O
01:18AM	O
URINE	O
RBC-<1	O
WBC-1	O
Bacteri-NONE	O
Yeast-NONE	O
Epi-0	O
___	O
01:18AM	O
URINE	O
CastHy-1*	O
___	O
04:19AM	O
BLOOD	O
WBC-14.2*	O
RBC-4.80	O
Hgb-15.0	O
Hct-44.8	O
MCV-93	O
MCH-31.3	O
MCHC-33.5	O
RDW-13.8	O
RDWSD-46.9*	O
Plt	O
___	O
___	O
04:19AM	O
BLOOD	O
Glucose-161*	O
UreaN-13	O
Creat-1.0	O
Na-140	O
K-4.7	O
Cl-101	O
HCO3-28	O
AnGap-16	O
___	O
04:19AM	O
BLOOD	O
GGT-87*	O
___	O
04:19AM	O
BLOOD	O
ALT-34	O
AST-41*	O
LD(LDH)-294*	O
CK(CPK)-338*	O
AlkPhos-63	O
TotBili-0.5	O
DirBili-<0.2	O
IndBili-0.5	O
___	O
05:12AM	O
BLOOD	O
ALT-25	O
AST-35	O
LD(LDH)-317*	O
AlkPhos-54	O
TotBili-0.5	O
___	O
04:58AM	O
BLOOD	O
ALT-41*	O
AST-143*	O
LD(___)-414*	O
AlkPhos-50	O
TotBili-1.5	O
DirBili-0.4*	O
IndBili-1.1	O
___	O
07:20AM	O
BLOOD	O
ALT-46*	O
AST-109*	O
LD(___)-405*	O
CK(CPK)-3636*	O
AlkPhos-55	O
TotBili-0.9	O
___	O
07:00AM	O
BLOOD	O
ALT-41*	O
AST-69*	O
LD(LDH)-365*	O
CK(CPK)-1545*	O
AlkPhos-55	O
TotBili-0.7	O
___	O
04:58AM	O
BLOOD	O
HBsAg-Negative	O
HBsAb-Negative	O
HBcAb-Negative	O
HAV	O
Ab-Negative	O
___	O
04:19AM	O
BLOOD	O
CK	O
338*	O
CK-MB-29*	O
MB	O
Indx-8.6*	O
cTropnT-0.35*	O
___	O
11:55AM	O
BLOOD	O
CK	O
615*	O
CK-MB-19*	O
MB	O
Indx-3.1	O
cTropnT-0.34*	O
___	O
05:12AM	O
BLOOD	O
CK-MB-7	O
cTropnT-0.39*	O
___	O
04:58AM	O
BLOOD	O
CK-MB-16*	O
cTropnT-0.27*	O
___	O
07:20AM	O
BLOOD	O
CK	O
3636*	O
CK-MB-10	O
MB	O
Indx-0.3	O
___	O
07:00AM	O
BLOOD	O
CK	O
1545*	O
___	O
06:55AM	O
BLOOD	O
CK	O
1178*	O
___	O
04:19AM	O
BLOOD	O
Albumin-3.7	O
Calcium-8.2*	O
Phos-3.7	O
Mg-2.6	O
Iron-65	O
Cholest-199	O
___	O
04:19AM	O
BLOOD	O
calTIBC-290	O
Hapto-<10*	O
Ferritn-182	O
TRF-223	O
___	O
04:58AM	O
BLOOD	O
Hapto-92	O
___	O
04:19AM	O
BLOOD	O
%HbA1c-6.1*	O
eAG-128*	O
___	O
04:19AM	O
BLOOD	O
Triglyc-328*	O
HDL-40	O
CHOL/HD-5.0	O
LDLcalc-93	O
___	O
04:19AM	O
BLOOD	O
TSH-0.46	O
___	O
06:55AM	O
BLOOD	O
WBC-9.9	O
RBC-4.02*	O
Hgb-12.5*	O
Hct-38.3*	O
MCV-95	O
MCH-31.1	O
MCHC-32.6	O
RDW-13.2	O
RDWSD-46.5*	O
Plt	O
___	O
___	O
06:55AM	O
BLOOD	O
___	O
PTT-31.2	O
___	O
___	O
06:55AM	O
BLOOD	O
Glucose-117*	O
UreaN-12	O
Creat-0.6	O
Na-137	O
K-3.8	O
Cl-101	O
HCO3-25	O
AnGap-15	O
___	O
06:55AM	O
BLOOD	O
Calcium-8.1*	O
Phos-3.0	O
Mg-2.0	O
___	O
06:55AM	O
BLOOD	O
ALT-46*	O
AST-64*	O
LD(LDH)-312*	O
CK(CPK)-1178*	O
AlkPhos-74	O
TotBili-0.9	O
___	O
CULTURE-	O
NO	O
GROWTH	O
___	O
CULTURE-	O
NO	O
GROWTH	O
___	O
CULTURE-	O
NO	O
GROWTH	O
___	O
CULTURE-	O
NO	O
GROWTH	O
___	O
CULTURE-	O
FINAL	O
Source:	O
Line-A.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
STAPHYLOCOCCUS	O
EPIDERMIDIS.	O
FINAL	O
SENSITIVITIES.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
CLINDAMYCIN-----------<=0.25	O
S	O
ERYTHROMYCIN----------<=0.25	O
S	O
GENTAMICIN------------	O
<=0.5	O
S	O
LEVOFLOXACIN----------<=0.12	O
S	O
OXACILLIN-------------<=0.25	O
S	O
VANCOMYCIN------------	O
1	O
S	O
___	O
CULTURE-	O
FINAL	O
Source:	O
Line-IJ.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
CLINDAMYCIN-----------<=0.25	O
S	O
ERYTHROMYCIN----------<=0.25	O
S	O
GENTAMICIN------------	O
<=0.5	O
S	O
LEVOFLOXACIN----------<=0.12	O
S	O
OXACILLIN-------------<=0.25	O
S	O
VANCOMYCIN------------	O
1	O
S	O
___	O
SCREEN-	O
NEGATIVE	O
___	O
CULTURE-	O
NO	O
GROWTH	O
___	O
STAIN-	O
FINAL;	O
RESPIRATORY	O
CULTURE-	O
FINAL	O
Source:Endotracheal.	O
**FINAL	O
REPORT	O
___	O
GRAM	O
STAIN	O
(Final	O
___:	O
>25	O
PMNs	O
and	O
>10	O
epithelial	O
cells/100X	O
field.	O
Gram	O
stain	O
indicates	O
extensive	O
contamination	O
with	O
upper	O
respiratory	O
secretions.	O
Bacterial	O
culture	O
results	O
are	O
invalid.	O
___	O
CULTURE-	O
NO	O
GROWTH	O
___	O
CULTURE-	O
NO	O
GROWTH	O
___	O
CULTURE-	O
NO	O
GROWTH	O
___	O
CULTURE-	O
NO	O
GROWTH	O
___	O
CULTURE-	O
NO	O
GROWTH	O
ECG	O
___	O
11:23:42	O
___	O
Sinus	O
rhythm.	O
There	O
is	O
a	O
late	O
transition	O
with	O
Q	O
waves	O
in	O
the	O
anterior	O
leads	O
and	O
ST	O
segment	O
elevation	O
concerning	O
for	O
acute	O
or	O
evolving	O
myocardial	O
infarction.	O
Additional	O
ST-T	O
wave	O
changes,	O
also	O
consistent	O
with	O
ischemia.	O
Clinical	O
correlation	O
is	O
suggested.	O
No	O
previous	O
tracing	O
available	O
for	O
comparison.	O
Echocardiogram	O
___	O
Left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal.	O
The	O
left	O
ventricular	O
cavity	O
is	O
mildly	O
dilated.	O
There	O
is	O
mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
hypokinesis	O
of	O
the	O
mid	O
to	O
distal	O
septum,	O
distal	O
anterior	O
wall,	O
and	O
true	O
apex	O
(LVEF	O
40%).	O
In	O
the	O
setting	O
of	O
suboptimal	O
image	O
quality	O
additional	O
wall	O
motion	O
abnormalities	O
cannot	O
be	O
fully	O
excluded.	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
not	O
well	O
seen.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Suboptimal	O
image	O
quality.	O
Mildy	O
dilated,	O
mildly	O
hypokinetic	O
left	O
ventricle	O
with	O
findings	O
consistent	O
with	O
(at	O
least)	O
mid-LAD	O
coronary	O
artery	O
disease.	O
Limited	O
assessment	O
for	O
valvular	O
pathology.	O
Indeterminate	O
pulmonary	O
artery	O
systolic	O
pressure.	O
CHEST	O
(PORTABLE	O
AP)	O
___	O
12:00	O
AM	O
No	O
comparison.	O
Lung	O
volumes	O
are	O
low.	O
The	O
patient	O
is	O
intubated,	O
the	O
tip	O
of	O
the	O
endotracheal	O
tube	O
projects	O
5	O
cm	O
above	O
the	O
carinal.	O
The	O
other	O
monitoring	O
and	O
support	O
devices	O
are	O
in	O
stable	O
position,	O
with	O
the	O
exception	O
of	O
the	O
intra-aortic	O
balloon	O
pump.	O
This	O
pump	O
is	O
currently	O
located	O
4.5	O
cm	O
be	O
low	O
the	O
upper	O
most	O
portion	O
of	O
the	O
aortic	O
arch.	O
Mild	O
elongation	O
of	O
the	O
descending	O
aorta.	O
Mild	O
to	O
moderate	O
pulmonary	O
edema.	O
No	O
pleural	O
effusions.	O
Mild	O
cardiomegaly.	O
No	O
pneumonia.	O
No	O
pneumothorax.	O
CHEST	O
(PORTABLE	O
AP)	O
___	O
4:42	O
AM	O
Comparison	O
to	O
___.	O
The	O
intra-aortic	O
balloon	O
pump	O
has	O
been	O
advanced.	O
The	O
tip	O
of	O
the	O
pump	O
is	O
now	O
within	O
1	O
cm	O
of	O
the	O
upper	O
most	O
portion	O
of	O
the	O
aortic	O
arch.	O
No	O
complications,	O
notably	O
no	O
pneumothorax.	O
The	O
other	O
monitoring	O
and	O
support	O
devices	O
are	O
stable.	O
No	O
pleural	O
effusions.	O
Stable	O
mild	O
pulmonary	O
edema.	O
CHEST	O
(PORTABLE	O
AP)	O
___	O
1:26	O
___	O
Endotracheal	O
tube	O
in-situ	O
with	O
the	O
tip	O
47	O
mm	O
proximal	O
to	O
the	O
carina.	O
Right-sided	O
IJV	O
CVP	O
in	O
situ	O
with	O
the	O
tip	O
in	O
the	O
distal	O
SVC.	O
No	O
right-sided	O
pneumothorax.	O
Intra-	O
aortic	O
balloon	O
pump	O
catheter	O
in	O
situ	O
with	O
the	O
tip	O
12	O
mm	O
inferior	O
to	O
the	O
top	O
of	O
the	O
aortic	O
arch.	O
Nasogastric	O
tube	O
in-situ	O
coursing	O
out	O
of	O
sight	O
inferiorly.	O
Interval	O
improvement	O
in	O
the	O
pulmonary	O
vascular	O
congestion/	O
interstitial	O
pulmonary	O
edema.	O
No	O
new	O
airspace	O
consolidation.	O
IMPRESSION:	O
Interval	O
improvement	O
in	O
the	O
pulmonary	O
vascular	O
congestion/	O
interstitial	O
edema.	O
Tubes	O
and	O
lines	O
as	O
described	O
above.	O
CHEST	O
PORT.	O
LINE	O
PLACEMENT	O
___	O
6:32	O
___	O
The	O
intra-aortic	O
balloon	O
pump	O
projects	O
3.9	O
cm	O
from	O
the	O
top	O
of	O
the	O
aortic	O
arch.	O
The	O
tip	O
of	O
the	O
endotracheal	O
tube	O
projects	O
over	O
the	O
mid	O
thoracic	O
trachea.	O
The	O
tip	O
of	O
the	O
gastric	O
tube	O
is	O
not	O
visualized.	O
A	O
right	O
internal	O
jugular	O
central	O
venous	O
catheter	O
tip	O
extends	O
to	O
the	O
distal	O
SVC.	O
Both	O
lung	O
bases	O
are	O
not	O
included	O
on	O
this	O
radiograph.	O
Within	O
this	O
limitation	O
there	O
is	O
no	O
focal	O
consolidation	O
or	O
pneumothorax	O
identified.	O
The	O
size	O
the	O
cardiac	O
silhouette	O
is	O
enlarged	O
but	O
unchanged.	O
IMPRESSION:	O
The	O
intra-aortic	O
balloon	O
pump	O
projects	O
3.9	O
cm	O
in	O
the	O
top	O
of	O
the	O
aortic	O
arch.	O
Limited	O
evaluation	O
of	O
the	O
lung	O
parenchyma	O
as	O
both	O
lung	O
bases	O
are	O
not	O
included	O
on	O
this	O
radiograph.	O
CHEST	O
(PORTABLE	O
AP)	O
___	O
7:18	O
AM	O
The	O
lung	O
volumes	O
are	O
stable.	O
Mild	O
cardiomegaly	O
with	O
unchanged	O
mild	O
interstitial	O
edema.	O
The	O
mediastinal	O
and	O
hilar	O
contours	O
are	O
unchanged.	O
The	O
left	O
pleural	O
surfaces	O
are	O
normal.	O
The	O
right	O
pleural	O
surfaces	O
are	O
normal	O
but	O
the	O
right	O
costophrenic	O
angle	O
is	O
not	O
seen	O
on	O
this	O
chest	O
radiograph.	O
The	O
ET	O
tube	O
terminates	O
within	O
4.5	O
cm	O
of	O
the	O
carina.	O
The	O
IABP	O
terminates	O
within	O
4.2	O
cm	O
of	O
the	O
superior	O
aspect	O
of	O
the	O
aortic	O
wall.	O
The	O
NG	O
tube	O
traverses	O
the	O
diaphragm	O
but	O
the	O
tip	O
is	O
not	O
visualized.	O
The	O
right	O
central	O
venous	O
catheter	O
terminates	O
in	O
the	O
mid	O
to	O
lower	O
SVC.	O
IMPRESSION:	O
Unchanged	O
mild	O
interstitial	O
edema.	O
CHEST	O
(PORTABLE	O
AP)	O
___	O
7:21	O
AM	O
Multiple	O
lines	O
and	O
tubes	O
have	O
been	O
removed.	O
Right	O
IJ	O
central	O
line	O
tip	O
overlies	O
the	O
mid	O
SVC.	O
No	O
pneumothorax	O
is	O
detected.	O
Mild	O
prominence	O
the	O
cardiomediastinal	O
silhouette	O
is	O
again	O
noted.	O
There	O
is	O
vascular	O
plethora	O
consistent	O
with	O
mild	O
CHF.	O
Patchy	O
opacity	O
at	O
both	O
lung	O
bases	O
is	O
slightly	O
more	O
pronounced	O
move	O
question	O
atelectasis,	O
but	O
evolving	O
CHF	O
or	O
other	O
etiologies	O
for	O
early	O
infiltrate	O
are	O
in	O
the	O
differential.	O
ABDOMEN	O
US	O
(COMPLETE	O
STUDY)	O
___	O
LIVER:	O
The	O
liver	O
is	O
diffusely	O
echogenic	O
with	O
areas	O
of	O
sparing,	O
likely	O
due	O
to	O
steatosis.	O
The	O
contour	O
of	O
the	O
liver	O
is	O
smooth.	O
There	O
is	O
no	O
focal	O
liver	O
mass.	O
The	O
main	O
portal	O
vein	O
is	O
patent	O
with	O
hepatopetal	O
flow.	O
There	O
is	O
no	O
ascites.	O
BILE	O
DUCTS:	O
There	O
is	O
no	O
intrahepatic	O
biliary	O
dilation.	O
The	O
CHD	O
measures	O
4	O
mm.	O
GALLBLADDER:	O
There	O
is	O
sludge	O
within	O
the	O
gallbladder,	O
but	O
no	O
evidence	O
of	O
acute	O
cholecystitis.	O
Multiple	O
small	O
gallbladder	O
wall	O
polps	O
are	O
seen	O
measuring	O
up	O
to	O
2	O
mm.	O
There	O
is	O
no	O
evidence	O
of	O
stones	O
or	O
gallbladder	O
wall	O
thickening.	O
PANCREAS:	O
The	O
pancreas	O
is	O
not	O
well	O
visualized,	O
largely	O
obscured	O
by	O
overlying	O
bowel	O
gas.	O
SPLEEN:	O
Normal	O
echogenicity,	O
measuring	O
9.6	O
cm.	O
KIDNEYS:	O
The	O
right	O
kidney	O
measures	O
9.6	O
cm.	O
The	O
left	O
kidney	O
measures	O
11.6	O
cm.	O
Normal	O
cortical	O
echogenicity	O
and	O
corticomedullary	O
differentiation	O
is	O
seen	O
bilaterally.	O
There	O
is	O
no	O
evidence	O
of	O
masses,	O
stones,	O
or	O
hydronephrosis	O
in	O
the	O
kidneys.	O
RETROPERITONEUM:	O
The	O
visualized	O
portions	O
of	O
aorta	O
and	O
IVC	O
are	O
within	O
normal	O
limits.	O
IMPRESSION:	O
1.	O
Echogenic	O
liver	O
consistent	O
with	O
steatosis.	O
Other	O
forms	O
of	O
liver	O
disease	O
including	O
steatohepatitis,	O
hepatic	O
fibrosis,	O
or	O
cirrhosis	O
cannot	O
be	O
excluded	O
on	O
the	O
basis	O
of	O
this	O
examination.	O
2.	O
Sludge	O
within	O
the	O
gallbladder	O
and	O
multiple	O
small	O
gallbladder	O
wall	O
polyps	O
measuring	O
up	O
to	O
2	O
mm,	O
however	O
no	O
evidence	O
of	O
acute	O
cholecystitis	O
or	O
biliary	O
dilatation.	O
UNILAT	O
LOWER	O
EXT	O
VEINS	O
RIGHT	O
___	O
6:47	O
___	O
There	O
is	O
normal	O
compressibility,	O
flow,	O
and	O
augmentation	O
of	O
the	O
right	O
common	O
femoral,	O
femoral,	O
and	O
popliteal	O
veins.	O
Normal	O
color	O
flow	O
and	O
compressibility	O
are	O
demonstrated	O
in	O
the	O
posterior	O
tibial	O
and	O
peroneal	O
veins.	O
There	O
is	O
normal	O
respiratory	O
variation	O
in	O
the	O
common	O
femoral	O
veins	O
bilaterally.	O
No	O
evidence	O
of	O
medial	O
popliteal	O
fossa	O
(___)	O
cyst.	O
IMPRESSION:	O
No	O
evidence	O
of	O
deep	O
venous	O
thrombosis	O
in	O
the	O
right	O
lower	O
extremity	O
veins.	O
CT	O
LOW	O
EXT	O
W/O	O
C	O
RIGHT	O
___	O
6:24	O
___	O
There	O
is	O
mild	O
subcutaneous	O
edema,	O
predominantly	O
along	O
the	O
lateral	O
aspect	O
of	O
the	O
right	O
lower	O
extremity.	O
There	O
is	O
mild	O
intramuscular	O
edema	O
involving	O
upper,	O
lateral	O
margin	O
of	O
the	O
soleus.	O
No	O
focal	O
fluid	O
collection	O
or	O
evidence	O
of	O
a	O
hematoma.	O
Evaluation	O
of	O
the	O
bony	O
structures	O
reveals	O
no	O
acute	O
fracture.	O
No	O
suspicious	O
lytic	O
or	O
sclerotic	O
lesion	O
is	O
identified.	O
There	O
is	O
a	O
small	O
suprapatellar	O
enthesophyte.	O
Mild	O
atherosclerotic	O
calcifications	O
are	O
noted.	O
IMPRESSION:	O
Nonspecific	O
subcutaneous	O
edema	O
lateral	O
aspect	O
of	O
the	O
right	O
lower	O
extremity.	O
Mild	O
intramuscular	O
edema	O
posterior	O
calf,	O
may	O
be	O
posttraumatic	O
or	O
inflammatory.	O
No	O
hematoma	O
or	O
fluid	O
collection.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
man	O
with	O
a	O
history	O
of	O
GERD,	O
untreated	O
hypertension,	O
active	O
tobacco	O
use,	O
alcohol	O
abuse,	O
and	O
probable	O
hyperlipidemia	O
who	O
presented	O
to	O
___	O
with	O
shortness	O
of	O
breath.	O
He	O
was	O
intubated	O
in	O
their	O
ED	O
and	O
was	O
found	O
to	O
have	O
an	O
anterior	O
wall	O
STEMI	O
with	O
100%	O
ostial	O
LAD	O
occlusion,	O
s/p	O
successful	O
reperfusion	O
with	O
aspiration	O
thrombectomy	O
and	O
a	O
DES	O
on	O
___,	O
complicated	O
by	O
periprocedural	O
hypotension	O
indicative	O
of	O
cardiogenic	O
shock	O
necessitating	O
balloon	O
pump	O
and	O
pressors,	O
transferred	O
to	O
___	O
for	O
further	O
management.	O
He	O
was	O
successfully	O
extubated	O
on	O
___,	O
weaned	O
off	O
pressors,	O
and	O
weaned	O
off	O
the	O
balloon	O
pump	O
in	O
the	O
CCU.	O
He	O
was	O
stable	O
for	O
transfer	O
to	O
the	O
cardiology	O
step-down	O
unit	O
on	O
___	O
with	O
a	O
hospital	O
course	O
notable	O
for	O
a	O
uncomplicated	O
catheter-associated	O
bloodstream	O
infection	O
with	O
Staph	O
epidermidis	O
treated	O
with	O
Vancomycin	O
for	O
5	O
days.	O
He	O
was	O
also	O
found	O
to	O
have	O
myositis	O
of	O
his	O
right	O
calf,	O
possibly	O
due	O
to	O
acute	O
statin	O
therapy.	O
#	O
Acute	O
coronary	O
syndrome/CAD:	O
Anterior	O
STEMI	O
with	O
100%	O
ostial	O
LAD	O
occlusion	O
s/p	O
successful	O
reperfusion	O
with	O
aspiration	O
thrombectomy	O
and	O
one	O
DES,	O
with	O
residual	O
70-80%	O
stenosis	O
LCx	O
(no	O
intervention)	O
and	O
100%	O
chronically	O
occluded	O
RCA.	O
Primary	O
PCi	O
at	O
___	O
was	O
complicated	O
by	O
periprocedural	O
hypotension	O
and	O
cardiogenic	O
shock	O
necessitating	O
balloon	O
pump	O
and	O
pressors.	O
Patient	O
was	O
transferred	O
to	O
the	O
step-down	O
unit	O
on	O
___	O
and	O
remained	O
hemodynamically	O
stable	O
without	O
evidence	O
of	O
spontaneous	O
ischemia.	O
Echocardiogram	O
revealed	O
mildy	O
dilated,	O
mildly	O
hypokinetic	O
left	O
ventricle	O
with	O
findings	O
consistent	O
with	O
(at	O
least)	O
mid-LAD	O
coronary	O
artery	O
disease	O
and	O
EF	O
40%.	O
Peak	O
CK-MB	O
29.	O
Patient	O
was	O
discharged	O
home	O
on	O
aspirin	O
81mg	O
daily,	O
ticagrelor	O
90	O
mg	O
twice	O
daily,	O
atorvastatin	O
80	O
mg	O
daily,	O
lisinopril	O
2.5	O
mg	O
daily,	O
and	O
metoprolol	O
succinate	O
XL	O
25	O
mg	O
daily.	O
Patient	O
scheduled	O
for	O
outpatient	O
Cardiology	O
follow	O
up	O
at	O
___	O
and	O
was	O
provided	O
a	O
prescription	O
and	O
referral	O
information	O
for	O
outpatient	O
cardiac	O
rehabilitation.	O
The	O
importance	O
of	O
smoking	O
cessation	O
was	O
discussed	O
with	O
the	O
patient.	O
#	O
Uncomplicated	O
catheter	O
associated	O
blood	O
stream	O
infection	O
with	O
Staph	O
epidermidis:	O
___	O
Blood	O
cultures	O
two	O
sets	O
with	O
___	O
bottles	O
grew	O
out	O
Staph	O
epidermidis	O
presumed	O
secondary	O
to	O
line	O
infection.	O
First	O
cleared	O
blood	O
culture	O
on	O
___.	O
CVL	O
and	O
IABP	O
were	O
promptly	O
removed	O
after	O
positive	O
culture	O
data	O
on	O
___.	O
Patient	O
treated	O
from	O
___	O
for	O
5	O
day	O
course	O
of	O
vancomycin.	O
#	O
Myositis	O
of	O
the	O
right	O
calf,	O
likely	O
statin	O
related:	O
Patient	O
found	O
to	O
have	O
myositis	O
of	O
right	O
calf	O
after	O
initiation	O
of	O
statin.	O
There	O
were	O
no	O
other	O
clear	O
triggers,	O
with	O
peak	O
total	O
CK	O
363,	O
downtrending	O
prior	O
to	O
discharge	O
off	O
statin.	O
Orthopedic	O
was	O
consulted,	O
with	O
no	O
concern	O
for	O
compartment	O
syndrome.	O
CT	O
imaging	O
consistent	O
with	O
intramuscular	O
edema	O
of	O
posterior	O
calf.	O
Calf	O
pain	O
improved	O
prior	O
to	O
discharge.	O
Statin	O
discontinued.	O
Although	O
the	O
patient's	O
catheterization	O
site	O
was	O
right	O
femoral,	O
it	O
is	O
unlikely	O
that	O
his	O
calf	O
pain	O
was	O
related	O
to	O
his	O
cardiac	O
catheterization	O
or	O
subsequent	O
IABP;	O
ultrasound	O
showed	O
no	O
evidence	O
of	O
DVT	O
or	O
___	O
cyst,	O
and	O
the	O
calf	O
lesion	O
was	O
not	O
contiguous	O
with	O
his	O
femoral	O
arteriotomy	O
site.	O
#	O
Transaminitis:	O
Patient	O
with	O
mildly	O
elevated	O
LFTs	O
on	O
admission.	O
Etiology	O
likely	O
multifactorial	O
given	O
his	O
history	O
alcohol	O
abuse	O
and	O
liver	O
imaging	O
showing	O
echogenic	O
liver	O
consistent	O
with	O
steatosis,	O
myocardial	O
necrosis	O
and	O
possible	O
congestive	O
hepatopathy	O
from	O
STEMI,	O
and	O
statin	O
induced	O
myositis	O
of	O
the	O
right	O
calf.	O
Hepatitis	O
serologies	O
were	O
negative	O
and	O
liver	O
enzymes	O
downtrending	O
upon	O
discharge.	O
#	O
Anemia:	O
Hemoglobin	O
16	O
on	O
admission	O
to	O
12	O
on	O
time	O
of	O
transfer	O
from	O
CCU	O
but	O
remained	O
stable	O
while	O
on	O
floor.	O
Initially	O
anemia	O
thought	O
to	O
be	O
secondary	O
to	O
hemolysis,	O
especially	O
with	O
high	O
LDH	O
&	O
low	O
haptoglobin	O
in	O
setting	O
of	O
IABP.	O
No	O
evidence	O
of	O
active	O
bleeding,	O
no	O
hematoma	O
in	O
right	O
thigh.	O
Smear	O
normal.	O
Discharge	O
Hgb	O
12.5.	O
#	O
Pressure-related	O
gluteal	O
induration:	O
Right	O
and	O
left	O
buttock	O
with	O
erythematous	O
induration	O
likely	O
from	O
lack	O
of	O
movement.	O
Patient	O
has	O
history	O
of	O
pilonidal	O
cysts	O
s/p	O
multiple	O
I&Ds.	O
He	O
was	O
seen	O
by	O
wound	O
care	O
who	O
recommended	O
keeping	O
Mepilex	O
in	O
place	O
with	O
change	O
every	O
3	O
days	O
and	O
follow	O
up	O
in	O
___	O
___	O
___	O
weeks	O
after	O
discharge.	O
#	O
H/O	O
alcohol	O
abuse:	O
Patient	O
monitored	O
on	O
CIWA	O
scale	O
and	O
was	O
not	O
clinically	O
withdrawing	O
this	O
admission.	O
****TRANSITIONAL	O
ISSUES****	O
Discharge	O
Weight:	O
84.2	O
kg	O
Discharge	O
Hgb:	O
12.5	O
Discharge	O
CK:	O
1178	O
-	O
Wound	O
care	O
consult	O
recommended	O
follow	O
up	O
in	O
___	O
specialties	O
___	O
weeks	O
post	O
discharge	O
-	O
Currently	O
not	O
on	O
statin	O
given	O
myositis,	O
consider	O
alternative	O
agent	O
(i.e.PCSK9	O
inhibitor)	O
or	O
consider	O
re-challenge	O
with	O
alternative	O
statin	O
in	O
outpatient	O
setting	O
-	O
On	O
Hepatitis	O
serology,	O
patient	O
is	O
NOT	O
IMMUNE	O
to	O
Hepatitis	O
B.	O
Transaminases	O
were	O
still	O
mildly	O
elevated	O
at	O
the	O
time	O
of	O
discharge.	O
Please	O
re-check	O
at	O
follow	O
up.	O
-	O
Patient's	O
calf	O
pain	O
and	O
CK	O
were	O
improving	O
at	O
the	O
time	O
of	O
discharge.	O
Confirm	O
continued	O
improvement.	O
Consider	O
rechecking	O
CK.	O
-	O
Prior	O
authorization	O
was	O
confirmed	O
with	O
insurance	O
company	O
for	O
ticagrelor	O
90	O
mg	O
BID.	O
PA	O
is	O
for	O
___	O
years.	O
First	O
month	O
supply	O
was	O
provided	O
at	O
the	O
time	O
of	O
discharge.	O
Case	O
ID:	O
___.	O
Patient	O
should	O
not	O
exceed	O
daily	O
aspirin	O
dose	O
of	O
more	O
than	O
100	O
mg	O
daily	O
while	O
on	O
ticagrelor.	O
He	O
should	O
remain	O
on	O
aspirin	O
for	O
life	O
and	O
ticagrelor	O
for	O
at	O
least	O
___	O
year	O
to	O
prevent	O
stent	O
thrombosis	O
and	O
for	O
post-MI	O
secondary	O
prevention	O
(mortality	O
benefit	O
compared	O
with	O
clopidogrel).	O
-	O
Ensure	O
compliance	O
with	O
new	O
medications,	O
aspirin/ticagrelor	O
in	O
particular	O
-	O
Refer	O
to	O
local	O
wound	O
care	O
clinic	O
or	O
specialist	O
for	O
gluteal	O
induration	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
2.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Moderate	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild/Fever	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
RX	O
*aspirin	O
81	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
Lisinopril	O
2.5	O
mg	O
PO	O
DAILY	O
RX	O
*lisinopril	O
2.5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
4.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
RX	O
*metoprolol	O
succinate	O
25	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
5.	O
TiCAGRELOR	O
90	O
mg	O
PO	O
BID	O
RX	O
*ticagrelor	O
[Brilinta]	O
90	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
per	O
day	O
Disp	O
#*60	O
Tablet	O
Refills:*0	O
6.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
7.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Moderate	O
8.R	I-Mobile_with_aid
OLLING	B-Mobile_with_aid
WALKER	B-Mobile_with_aid
ICD	O
10	O
CODE:	O
___.9	O
PX:	O
good	O
___:	O
13	O
months	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
-Anterior	O
ST	O
segment	O
elevation	O
myocardial	O
infarction,	O
complicated	O
by	O
-Cardiogenic	O
shock	O
requiring	O
vasopressors	O
and	O
an	O
intra-aortic	O
balloon	O
pump	O
-Coronary	O
artery	O
disease,	O
3	O
vessel,	O
with	O
chronic	O
total	O
occlusion	O
of	O
the	O
right	O
coronary	O
artery	O
-Mild	O
acute	O
left	O
ventricular	O
systolic	O
heart	O
failure	O
-Uncomplicated	O
vascular	O
catheter	O
associated	O
bloodstream	O
infection	O
(Staphylococcus	O
epidermidis)	O
-Likely	O
statin	O
induced	O
myositis	O
of	O
the	O
right	O
calf	O
-Gastroesophageal	O
reflux	O
disease	O
-History	O
of	O
alcohol	O
abuse	O
-Anemia	O
-Transaminitis	O
-Osteoarthritis	O
with	O
chronic	O
use	O
of	O
narcotis	O
-Pressure	O
related	O
gluteal	O
induration	O
-Tobacco	O
abuse	O
with	O
recent	O
use	O
of	O
cigarettes	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
the	O
___	O
___.	O
You	O
were	O
admitted	O
because	O
you	O
had	O
a	O
heart	O
attack.	O
It	O
is	O
very	O
important	O
to	O
take	O
all	O
of	O
your	O
heart	O
healthy	O
medications.	O
Very	O
importantly,	O
you	O
are	O
now	O
taking	O
aspirin	O
and	O
ticagrelor.	O
These	O
two	O
medications	O
keep	O
the	O
stents	O
in	O
the	O
vessels	O
of	O
the	O
heart	O
open	O
and	O
help	O
reduce	O
your	O
risk	O
of	O
having	O
a	O
future	O
heart	O
attack.	O
If	O
you	O
stop	O
these	O
medications	O
or	O
miss	O
___	O
dose,	O
you	O
risk	O
causing	O
a	O
blood	O
clot	O
forming	O
in	O
your	O
heart	O
stents,	O
and	O
you	O
may	O
die	O
from	O
a	O
massive	O
heart	O
attack.	O
Please	O
do	O
not	O
stop	O
taking	O
either	O
medication	O
without	O
taking	O
to	O
your	O
heart	O
doctor,	O
even	O
if	O
another	O
doctor	O
tells	O
you	O
to	O
stop	O
the	O
medications.	O
You	O
were	O
found	O
to	O
have	O
an	O
infection	O
in	O
your	O
blood	O
stream	O
that	O
was	O
treated	O
with	O
antibiotics.	O
This	O
was	O
an	O
infection	O
likely	O
caused	O
by	O
the	O
emergent	O
catheters	O
you	O
had	O
to	O
received	O
in	O
the	O
intensive	O
care	O
unit	O
so	O
you	O
could	O
receive	O
medications	O
to	O
help	O
you	O
recover	O
from	O
your	O
heart	O
attack.	O
Unfortunately	O
you	O
had	O
a	O
bad	O
reaction	O
to	O
atorvastatin	O
(Lipitor)	O
and	O
you	O
had	O
muscle	O
inflammation	O
of	O
your	O
right	O
calf.	O
We	O
had	O
to	O
stop	O
the	O
atorvastatin.	O
This	O
"statin"	O
medication	O
is	O
important	O
to	O
keep	O
your	O
heart	O
healthy	O
so	O
in	O
the	O
future,	O
your	O
cardiologist	O
or	O
primary	O
care	O
physician	O
may	O
try	O
another	O
statin-type	O
of	O
medication	O
in	O
the	O
future.	O
Please	O
STOP	O
SMOKING.	O
Smoking	O
is	O
a	O
MAJOR	O
RISK	O
FACTOR	O
for	O
a	O
heart	O
attack.	O
At	O
discharge,	O
you	O
weighed	O
185.6	O
lbs.	O
Please	O
weigh	O
yourself	O
every	O
day	O
in	O
the	O
morning	O
after	O
you	O
go	O
to	O
the	O
bathroom	O
and	O
before	O
you	O
get	O
dressed.	O
If	O
your	O
weight	O
goes	O
up	O
by	O
more	O
than	O
3	O
lbs	O
in	O
1	O
day	O
or	O
more	O
than	O
5	O
lbs	O
in	O
3	O
days,	O
please	O
call	O
your	O
heart	O
doctor	O
or	O
your	O
primary	O
care	O
doctor	O
and	O
alert	O
them	O
to	O
this	O
change.	O
THESE	O
ARE	O
YOUR	O
HEART	O
MEDICATIONS	O
TO	O
TAKE	O
DAILY:	O
Aspirin	O
81	O
mg	O
DAILY	O
Lisinopril	O
2.5	O
mg	O
DAILY	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
DAILY	O
TiCAGRELOR	O
90	O
mg	O
PO/NG	O
TWICE	O
PER	O
DAY	O
If	O
you	O
have	O
pain,	O
avoid	O
advil/motrin/aleve.	O
Do	O
not	O
take	O
more	O
than	O
81mg	O
of	O
aspirin	O
per	O
day.	O
You	O
can	O
take	O
acetaminophen	O
(tylenol)	O
but	O
avoid	O
more	O
than	O
3000mg	O
per	O
day.	O
We	O
wish	O
you	O
the	O
best	O
with	O
your	O
health,	O
Your	O
___	O
Cardiac	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

